Company / Accounts Receivable
PURE BIOSCIENCE, INC. Accounts Receivable History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$474.0K
FY2025
5-year range
$201.0K / $474.0K
FY2021-FY2025
Trend
+59.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Accounts Receivable has increased for 3 consecutive years, from $201,000 in FY2022 to $474,000 in FY2025.
Based on SEC 10-K filings.
$474,000 in FY2025 with a 5-year CAGR of -15.3%.
Improved from $285,000 to $474,000 over the past 2 years.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +33.1%
- 5-Year CAGR
- -15.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- PURE BIOSCIENCE, INC.'s accounts receivable has grown for 3 consecutive years.
- 5-year CAGR of -15.3%, indicating a declining trend.
- In FY2025, accounts receivable increased 59.1% year-over-year.
- Peak accounts receivable was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -116.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $474.0K | +59.1% |
| FY2024 | $298.0K | +4.6% |
| FY2023 | $285.0K | +41.8% |
| FY2022 | $201.0K | -45.4% |
| FY2021 | $368.0K | -66.2% |
| FY2020 | $1.1M | +192.0% |
| FY2019 | $373.0K | +35.6% |
| FY2018 | $275.0K | -7.4% |
| FY2017 | $297.0K | +12.9% |
| FY2016 | $263.0K | +39.2% |
As of FY2025 · SEC Form 10-K · Last checked Jun 29, 2026